Biomedical Engineering Reference
In-Depth Information
(e) technological developments from universities and national laboratories,
(f) analysis of funding sources and critical mergers and acquisitions,
(g) key patents.
The report is an excellent resource at present. However, as is the case with all other reports
that emphasize economic analysis of biosensor markets, they will lose their full value in
about a year or so due to the rapidly changing biosensor market and landscape. Nevertheless,
these types of reports have some lasting value as they provide a perspective, based on which
one can analyze further in particular to suit one's environment.
Eisner et al.
(
2009
)
of the Center for Healthcare Management at the Leipzig Graduate School
of Management in Leipzig, Germany, have come up with an interesting economic model for
biosensor applications in the medical industries. They point out that many medical decisions
are initiated by technical feasibility rather than by economic feasibility. The authors empha-
size that economic feasibility is gradually coming to the forefront since payoffs and health
economic considerations are becoming more and more important. However, economic infor-
mation in the literature, if available, targets only a single economic consideration, and even
that for a specific aspect or a particular cohort of patients (such as patients who have suffered
a stroke). In order that this economic aspect may be addressed in a more general sense for
biosensor applications and corresponding planning decisions, as well as for presentations,
and negotiations, the authors have developed a methodology to collect more relevant data
for these economic feasibility studies. Considering the present emphasis on health care,
and the urgent need to bring health care costs down, here in United States, as well as through-
out the world, the analysis should be valuable. Also, the move to include more and more
families and individuals under the health care umbrella (especially those that are under-or
un-insured) is bound to place more pressure on finding ways and means to cut down delivery
costs in health care.
(about one percent of the present cost of biosensors), and this will lead to a medical revolu-
tion. A cell phone coupled with a biosensor used on a drop of blood should reveal the health
of an individual. This according to the author should take place in the next 3-5 years.
The author claims that since biosensors will be produced in a manner similar to transistors,
the process will go into an economic free-fall. The authors emphasize that the demand for
biosensors has increased at breakneck speed. Present-day electrochemical and optically based
biosensors are expensive. The author opines that in the next 3-5 years tailor-made biosensors
combined with chips will be developed.
biosensors. The author opines that the demand for specific, low-cost, rapid and easy detection
of different analytes is ever increasing. A good example is, of course, the use of biosensors
